Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Wealth management is crucial for women looking to grow their assets. Discover expert tips tailored to help women succeed in managing their wealth.
18,468 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Nio is signaling a major profitability milestone with its first adjusted profit, but the real impact for investors de...
A private defense contractor is pushing the Navy toward autonomous, unmanned surface ships. This article explains the...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
Reddit has shown surprising business momentum, but its stock slide has puzzled investors. This guide breaks down what...
Rising protection costs for rental properties are squeezing profits. This guide explains why landlord insurance premi...
As CPS Tech nears its Q4 2025 results, investors seek clarity on revenue, margins, and strategy. This guide breaks do...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
Circle Inc.’s public shares jumped again on Tuesday as Bernstein maintained an upbeat view on the company, pointing t...
In a turbulent 2026 market, CVS Health and Cigna are at the center of retirement portfolio debates. This piece weighs...
RF Industries (RFIL) faces a mix of aerospace, medical, and data-communications demand in 2026. This guide breaks dow...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...